Special Categories


Breadcrumb Navigation


Cancer Category

Novel Formulation Of Vitamin E Extract Could Tackle Tumors Without Damaging Healthy Tissue

Posted December 10th, 2009 by RedScrubs.com

Top News

Here is our Top News Post for today, brought to you by StaffPointe



One In Three Detected Breast Cancers Is Overdiagnosed

Posted July 10th, 2009 by RedScrubs.com

Top News

Here is our Top News Post for today, brought to you by StaffPointe:


  • One In Three Detected Breast Cancers Is Overdiagnosed
  • (Report via Medical News Today)Researchers conclude in a paper just published on bmj.com that one in three breast cancers detected in a population with a public breast screening program is overdiagnosed.

    Some cancers are harmless and will not cause symptoms or death during a patient’s lifetime. The cancer grows so slowly that the patient dies of other causes before it produces symptoms, or the cancer remains dormant or regresses. Overdiagnosis refers to the detection of those cancers.


Top NEWS Post 4-14-2009

Posted April 14th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • Nutritional Therapy May Benefit Cancer Patients Undergoing Major Operations
  • New research from Trinity College Dublin published in this month’s Annals of Surgery points to a potentially significant advance in the treatment of patients undergoing major cancer surgery. The study was carried out by the esophageal research group at Trinity College Dublin and St James’s Hospital.
    A randomized controlled trial showed omega-3 fatty acids given as part of an oral nutritional supplement resulted in the preservation of muscle mass in patients having surgery for esophageal cancer.


Top NEWS Post 4-9-2009

Posted April 9th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • Drug Resistant Prostate Cancer: New Medications Show Promise
  • A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Of 30 men who received low doses of one the drugs in a multisite phase I/II trial designed to evaluate safety, 22 showed a sustained decline in the level of prostate specific antigen (PSA) in their blood.


Top NEWS Post 3-25-2009

Posted March 25th, 2009 by RedScrubs.com

Top News

Here is our Top News Post for today, brought to you by MedReader:


  • Study Looks At Celebrex And Lipitor To Treat Prostate Cancer
  • The FDA-approved drugs Celebrex® and Lipitor® used respectively for arthritis pain and lowering one’s cholesterol are being tested by investigators at The Cancer Institute of New Jersey (CINJ) to see if they hold any promise in slowing or stopping the growth of prostate cancer when combined. CINJ is a center of excellence of UMDNJ-Robert Wood Johnson Medical School.


Top NEWS Post 3-16-2009

Posted March 16th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • New Data On Link Between Cancer And Nutrition Discussed At European Symposium
  • European experts in cancer and nutrition are meeting in Zurich, Switzerland late this month to discuss cutting-edge research in one of the most important and fiercely debated topics in cancer prevention: the link between diet and cancer. There is growing evidence that many cancers may be prevented through healthy lifestyle, including a nutritionally balanced diet.


Top NEWS Post 3-9-2009

Posted March 9th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • Serious Flaws In Study On Vitamin C Treatment In Cancer
  • Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary Therapies.


Top NEWS Post 2-26-2009

Posted February 26th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • Determining Risk For Pancreatic Cancer
  • In the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.


Top NEWS Post 2-16-2009

Posted February 16th, 2009 by RedScrubs.com

Top News

Here is our Top Blog Post for today, brought to you by MedReader:


  • New Mechanism Involved In Tumor Development Discovered That Could Lead To An Innovative Treatment/li>
    The development of cancerous tumors is highly dependent on the nutrients the tumors receive through the blood. The team of Dr. Janusz Rak, of the Research Institute of the McGill University Health Centre (MUHC) at the Montreal Children’s Hospital, including Dr. Rak, has just discovered a new mechanism that tumors use to stimulate the growth of the blood vessels that feed them.



Note: This is the end of the usable page. The images below are preloaded for performance only.